NCT07361003 2026-01-22A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal CancerJiangsu Simcere Pharmaceutical Co., Ltd.Phase 3 Recruiting464 enrolled
NCT05405595 2026-01-07ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid TumorsAdagene IncPhase 1/2 Recruiting186 enrolled
NCT06873763 2025-07-11Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal CancerSTCube, Inc.Phase 1/2 Recruiting52 enrolled